For example, LY364947, a TGF-β inhibitor, encapsulated in mesoporous silica nanoparticles, reduced MDSC-induced immunosuppression, enhancing GEM delivery and decreasing tumor growth in pancreatic cancer models [43]. This evidence concerns the gene TGFB1 and neoplasm.